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INTRODUCTION:  Thymic  mucosa-associated  lymphoid  tissue  (MALT)  lymphoma  involving  lymph  nodes
is  quite  rare  with only  13  previous  cases  reported  in the  literature.
PRESENTATION OF  CASE:  The  33-years-old  female  was  referred  to  our department  for  the  investigation
of  abnormalities  on  computed  tomographic  (CT)  scans.  CT  scans  showed  a 9-cm  × 3-cm mass  composed
of  a mixture  of  soft  tissue  and fat at the  anterior  mediastinum  with  lymphadenopathy  in  the  neck,  axil-
lary  and  mediastinal  regions.  She  was  underwent  complete  surgical  resection  of the mass  with  regional
lymph  node  dissection  through  a median  sternotomy.  Histological  examination  of the  surgical  specimens
conﬁrmed  the  diagnosis  of  MALT  lymphoma  arising  in the thymus  with  nodal  metastasis.  She  achieved
complete  remission  after  postoperative  rituximab  combined  chemotherapy.
DISCUSSION: Thymic  MALT  lymphoma  occurs  most  frequently  in  Asian  female  aged  40–60  years  and
commonly  appears  anterior  mediastinal  masses  on  CT  scans.  The excised  tissue  is  necessary  to  conﬁrm
the  accurate  histological  diagnosis.  The  disease  usually  remains  localized  for a  long  time,  making  local
surgical  resection  highly  effective.  However,  when  the  lymph  nodes  are  involved,  effective  treatment
approaches  of the  disease  is  still  undeﬁned.
CONCLUSION: We  report  a  case  of thymic  MALT  lymphoma  involving  lymph  nodes,  in  which  the  patient
was  successfully  treated  with  primary  site  resection  with  regional  lymph  node  dissection  followed  by
rituximab  combined  chemotherapy.  Surgery  provided  not  only  a useful  approach  for  collecting  tissue  for
an  accurate  histological  diagnosis,  but  also  an  effective  local  treatment,  even  in  the  case  of  advanced-stage
thymic  MALT  lymphoma.
gical © 2012 Sur
. Introduction
Mucosa-associated lymphoid tissue (MALT) lymphoma, or
xtranodal marginal zone lymphoma of MALT, is a low-grade B-
ell non-Hodgkin’s lymphoma.1–7 MALT lymphoma occurs most
requently in the Waldeyer ring, gastrointestinal tract, skin, lungs,
hyroid, salivary glands, and orbit; thymic MALT lymphoma is quite
are. In fact, approximately 50 cases of thymic MALT lymphoma
ave been reported in the literature.1–7 These reports demonstrate
hat thymic MALT lymphoma usually grows locally and responds
ell to surgery, and the involvement of lymph nodes is unusual,
ith only 13 prior cases reported in the literature.2,5 Because of
he rarity of advanced-stage thymic MALT lymphoma, a standard
reatment for the disease has not been fully deﬁned yet.
Here,  we report a case of thymic MALT lymphoma involving
he lymph nodes, which was successfully managed with complete
urgical resection with regional lymph node dissection followed by
ituximab combined chemotherapy.∗ Corresponding author at: 222-1 Kamikitate, Akita City, Akita 010-1495, Japan.
el.:  +81 18 829 5000; fax: +81 18 829 5255.
E-mail address: hidekiohta29@hotmail.com (H. Ota).
210-2612 ©   2012 Surgical Associates Ltd. Published by Elsevier Ltd. 
ttp://dx.doi.org/10.1016/j.ijscr.2012.12.002
Open access under CC BY-Associates Ltd. Published by Elsevier Ltd. 
2. Presentation of case
A 33-year-old female with no history of smoking was  referred
to our department for the investigation of an anterior mediastinal
mass, detected incidentally on a postoperative follow-up computed
tomographic (CT) scan for thyroid cancer. She underwent total
thyroidectomy with bilateral modiﬁed radical neck dissection for
papillary thyroid carcinoma 3 years ago: Stage I (T2N0M0). There
was no evidence of recurrent thyroid cancer.
On admission, she was  asymptomatic. Her body tempera-
ture was  36.5 ◦C, blood pressure was 112/73 mmHg, and pulse
was 85 beats per min. A surgical scar was  noted on her neck.
There were no abnormalities of the chest or abdomen and no
neurological abnormalities. Laboratory data showed slightly ele-
vated serum lactic dehydrogenase (239 IU/L). Her thyroid levels
were normal since she had been receiving thyroid hormone
replacement therapy. Serum immunoglobulin levels were found
to be within the normal range and autoantibodies were not
detected.
CT scans showed a 9-cm × 3-cm mass composed of a mixture of
soft tissue and fat at the anterior mediastinum (Fig. 1). The central
Open access under CC BY-NC-ND license.part of the mass was  irregularly enhanced by contrast medium.
Lymphadenopathy was found in the neck, axillary and mediastinal
regions, but not in abdominal or inguinal regions. Surgical excision
of the tumor through a median sternotomy was performed because
NC-ND license.
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4ig. 1. Chest CT scan demonstrated the anterior mediastinal mass (arrow) with
ediastinal and axillary lymphadenopathy (arrowhead).
ALT lymphoma arising in the thymus was mostly suspected on
he basis of image ﬁndings.
During surgery, an elastic soft mass in the anterior mediastinum
as easily removed from the surrounding tissue. Intra-operative
athologic examination of the specimen obtained from left lobe
hymectomy showed inﬁltration of lymphoid cells around Hassall’s
orpuscle, suggesting thymic MALT lymphoma. Therefore, com-
lete surgical resection with regional lymph node dissection was
erformed.
The resected tumor, which was white-gray in color, measured
0.5 cm × 7 cm × 2 cm and weighed 82 g. Histological examination
howed that the normal architecture of the thymus was diffusely
ffaced by a dense inﬁltration of CD20-positive lymphoid cells
Figs. 2 and 3). No local invasion into surrounding tissue was
ound. Lymphoepithelial lesions were formed by centrocyte-like
ells inﬁltrating the Hassall’s corpuscles. Lymphoma cells were
ound in the resected lymph nodes.
The mediastinal tumor was diagnosed as a MALT-type B-cell
ymphoma. Lymphadenopathy in the neck and axillary regions
as suspected to have relevance to nodal metastasis of MALT
ymphoma. Bone marrow aspiration revealed no inﬁltration by
ymphoid cells and no chromosomal abnormalities. The patient’s
ostoperative course was uneventful, and she was discharged on
he 10th postoperative day. She received 8 courses of R-CHOP ther-
py (rituximab, cyclophosphamide, doxorubicin, vincristine, and
rednisolone) and achieved complete remission without severe
ig. 2. Pathological ﬁndings of the resected specimen. Small lymphocytes inﬁltrated
he  thymic tissue and some centrocyte-like cells invaded the epithelium of Has-
all’s corpuscles, forming lymphoepithelial lesions (Hematoxylin and Eosin staining,
0×).Fig. 3. Immunohistochemical staining of CD20 in the cytoplasm of tumor cells
(200×).
adverse reactions 6 months after operation. She has been well for
5 years without relapse.
3. Discussion
Thymic MALT lymphomas often take an indolent course and
remain localized for prolonged periods, making local surgical
excision highly effective.1–7 However, an optimal strategy in the
management of thymic MALT lymphoma with nodal metastasis is
still controversial. In the present case, thymic MALT lymphoma was
diagnosed by surgical specimens, and the patient responded well
to surgical treatment and postoperative R-CHOP therapy. Surgery
facilitated the establishment of an accurate histological diagnosis
and provided an effective local treatment for the primary tumor,
even in advanced-stage thymic MALT lymphoma.
Thymic MALT lymphoma has unique characteristics compared
with MALT lymphoma in other organs.1–7 For example, thymic
MALT lymphomas occur most frequently in Asian female aged
40–60 years and usually appear on CT scans as anterior medi-
astinal masses with multiple solid cystic regions. In some cases,
pulmonary amyloid nodules associated with polyclonal hyperglob-
ulinemia are found,8,9 and immunological disorders, particularly
Sjögren syndrome, are thought to be associated with thymic
MALT lymphoma tumorigenesis. Moreover, prolonged antigenic
stimulation by autoantigens or chronic inﬂammation in patients
with thymic lymphoid hyperplasia may  allow the development of
MALT lymphoma.10 Although API2-MALT1 fusion resulting from
t(11;18)(q21;q21) is present in up to 50% of MALT lymphomas in
general, this chromosomal translocation is not detected in thymic
MALT lymphoma.
Thymic MALT lymphoma is usually diagnosed by histolog-
ical examination of surgical specimens.1–6 In adults, primary
mediastinal lymphomas, which represent approximately 5–7%
of mediastinal tumors operated on in Japan,11 are generally
diagnosed as Hodgkin’s lymphoma, primary mediastinal large B-
cell lymphoma, or thymic MALT lymphoma using histology and
immunohistochemistry. Thymic MALT lymphoma is difﬁcult to
diagnose from small tissue fragments obtained by percutaneous
needle biopsy.12 Therefore, surgical resection is a suitable alterna-
tive approach to obtaining enough tissue for accurate histological
diagnosis.6
Postoperative recurrence after complete surgical resection is
considered to be rare since thymic MALT lymphoma generally
presents as a nonmetastasized completely encapsulated tumor.5,6
Only 3 cases of postoperative recurrence of thymic MALT lym-
phoma have been reported to date; one case of bone marrow
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etastasis2 and 2 cases of distant lymph nodes metastasis.6
or these reasons, Sunohara et al.5 recommended that total
hymectomy through a median sternotomy should be an effec-
ive procedure for removal of the primary lesion. In addition,
amada et al.13 recently reported a minimally invasive tumor
issection procedure using video-assisted thoracoscopic surgery.
owever, these techniques require careful attention due to lack
f lymph node dissection. Lymphoma cells often involved the
egional lymph nodes.2 Patients without recurrence have gen-
rally received postoperative radiation therapy, indicating that
emnants in the regional lymph nodes may  be managed with that
reatment.2 Therefore, total thymectomy or tumor dissection may
esult in failure to remove involved regional lymph nodes com-
letely, potentially leading to postoperative recurrence. Thus, we
ecommended en bloc resection of thymic MALT lymphoma and
ediastinal lymph nodes for local treatment.
A commonly accepted treatment strategy for thymic MALT lym-
homa involving lymph nodes has not been established.6 In the
urrent case, we used primary site resection followed by ritux-
mab combined chemotherapy to achieved complete remission of
dvanced-stage thymic MALT lymphoma. To the best of our knowl-
dge, this is the ﬁrst report of successful treatment of rituximab
ombined chemotherapy for the disease. Rituximab, a chimeric
onoclonal antibody targeting CD20, is a highly effective agent
n B-cell non-Hodgkin’s lymphoma, and several clinical trials are
urrently evaluating the activity of the combination of rituximab
nd chemotherapy in MALT lymphoma.14,15 Our case suggests that
ituximab combined chemotherapy would be effective with low
oxicity in thymic MALT lymphoma.
. Conclusion
Here, we reported a rare case of thymic MALT lymphoma involv-
ng lymph nodes that was successfully managed by complete
urgical resection with regional lymph node dissection followed
y postoperative rituximab combined chemotherapy. In this case,
urgery facilitated histological diagnosis and local treatment of the
rimary tumor.
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